NasdaqGS - Delayed Quote USD
Amylyx Pharmaceuticals, Inc. (AMLX)
4.9200
+0.6900
+(16.31%)
At close: 4:00:00 PM EDT
4.9022
-0.02
(-0.36%)
After hours: 6:42:41 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 698,837 | 9 |
Sales | 138,210 | 15 |
Net Shares Purchased (Sold) | 560,627 | 24 |
Total Insider Shares Held | 10.33M | -- |
% Net Shares Purchased (Sold) | 5.70% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
BEDROSIAN CAMILLE L Officer | Sale at price 3.47 per share. | Direct | 43,082 | Mar 31, 2025 |
FRATES JAMES MATTHEW Chief Financial Officer | Sale at price 3.47 per share. | Direct | 37,806 | Mar 31, 2025 |
COHEN JOSHUA BARRY Chief Executive Officer | Sale at price 3.47 per share. | Direct | 74,482 | Mar 31, 2025 |
KLEE JUSTIN B Chief Executive Officer | Sale at price 3.46 per share. | Direct | 74,454 | Mar 31, 2025 |
MAZZARIELLO GINA Officer | Sale at price 3.48 per share. | Direct | 31,954 | Mar 31, 2025 |
ZEIHER BERNHARDT G Director | Purchase at price 3.70 per share. | Direct | 37,005 | Mar 20, 2025 |
BEDROSIAN CAMILLE L Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2025 |
FRATES JAMES MATTHEW Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2025 |
COHEN JOSHUA BARRY Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2025 |
KLEE JUSTIN B Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2025 |
MAZZARIELLO GINA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2025 |
COHEN JOSHUA BARRY Chief Executive Officer | Sale at price 3.17 per share. | Direct | 14,549 | Mar 3, 2025 |
KLEE JUSTIN B Chief Executive Officer | Sale at price 3.15 per share. | Direct | 14,483 | Mar 3, 2025 |
MAZZARIELLO GINA Officer | Sale at price 3.12 per share. | Direct | 5,022 | Mar 3, 2025 |
MAZZARIELLO GINA Officer | Sale at price 3.15 per share. | Direct | 13,145 | Feb 24, 2025 |
KLEE JUSTIN B Chief Executive Officer | Conversion of Exercise of derivative security at price 1.57 per share. | Direct | 57,007 | Feb 5, 2025 |
COHEN JOSHUA BARRY Chief Executive Officer | Sale at price 3.47 per share. | Direct | 41,108 | Feb 3, 2025 |
KLEE JUSTIN B Chief Executive Officer | Sale at price 3.47 per share. | Direct | 41,104 | Feb 3, 2025 |
MAZZARIELLO GINA Officer | Sale at price 3.49 per share. | Direct | 12,839 | Feb 3, 2025 |
MILNE GEORGE MCLEAN JR Director | Stock Gift at price 0.00 per share. | Direct | 0 | Jan 24, 2025 |
COHEN JOSHUA BARRY Chief Executive Officer | Sale at price 4.05 per share. | Direct | 30,232 | Jan 6, 2025 |
KLEE JUSTIN B Chief Executive Officer | Sale at price 4.04 per share. | Direct | 30,202 | Jan 6, 2025 |
BEDROSIAN CAMILLE L Officer | Sale at price 5.54 per share. | Direct | 30,007 | Dec 2, 2024 |
KLEE JUSTIN B Chief Executive Officer | Conversion of Exercise of derivative security at price 1.57 per share. | Direct | 99,993 | Nov 4, 2024 |
BEDROSIAN CAMILLE L Officer | Sale at price 3.20 per share. | Direct | 36,559 | Sep 30, 2024 |
COHEN JOSHUA BARRY Chief Executive Officer | Sale at price 3.20 per share. | Direct | 59,414 | Sep 30, 2024 |
KLEE JUSTIN B Chief Executive Officer | Sale at price 3.20 per share. | Direct | 59,429 | Sep 30, 2024 |
MAZZARIELLO GINA Officer | Sale at price 3.20 per share. | Direct | 27,840 | Sep 30, 2024 |
COHEN JOSHUA BARRY Chief Executive Officer | Conversion of Exercise of derivative security at price 1.57 per share. | Direct | 2,915 | Sep 23, 2024 |
FRATES JAMES MATTHEW Chief Financial Officer | Purchase at price 2.53 per share. | Direct | 101,368 | Sep 12, 2024 |
COHEN JOSHUA BARRY Chief Executive Officer | Conversion of Exercise of derivative security at price 1.57 per share. | Direct | 54,085 | Sep 12, 2024 |
FIRESTONE KAREN M. Director | Purchase at price 2.13 per share. | Direct | 106,590 | Sep 5, 2024 |
MILNE GEORGE MCLEAN JR Director | Purchase at price 2.20 per share. | Direct | 219,800 | Sep 3, 2024 |
MAZZARIELLO GINA Officer | Sale at price 1.88 per share. | Direct | 19,654 | May 15, 2024 |
QUIMI DAPHNE Director | Purchase at price 1.88 - 1.89 per share. | Direct | 9,436 | May 15, 2024 |
BEDROSIAN CAMILLE L Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 16, 2024 |
FRATES JAMES MATTHEW Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 16, 2024 |
COHEN JOSHUA BARRY Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 16, 2024 |
KLEE JUSTIN B Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 16, 2024 |
MAZZARIELLO GINA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 16, 2024 |
FRATES JAMES MATTHEW Chief Financial Officer | Sale at price 18.73 per share. | Direct | 33,560 | Mar 5, 2024 |
COHEN JOSHUA BARRY Chief Executive Officer | Sale at price 18.73 per share. | Direct | 77,440 | Mar 5, 2024 |
KLEE JUSTIN B Chief Executive Officer | Sale at price 18.73 per share. | Direct | 77,440 | Mar 5, 2024 |
MAZZARIELLO GINA Officer | Sale at price 18.73 per share. | Direct | 28,841 | Mar 5, 2024 |
FRATES JAMES MATTHEW Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 26, 2024 |
COHEN JOSHUA BARRY Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 26, 2024 |
KLEE JUSTIN B Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 26, 2024 |
MAZZARIELLO GINA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 26, 2024 |
MAZZARIELLO GINA Officer | Sale at price 18.76 per share. | Direct | 53,231 | Feb 23, 2024 |
MILNE GEORGE MCLEAN JR Director | Stock Gift at price 0.00 per share. | Direct | 0 | Jan 25, 2024 |
Related Tickers
VTYX Ventyx Biosciences, Inc.
1.1800
+4.42%
DAWN Day One Biopharmaceuticals, Inc.
7.33
+2.66%
IMVT Immunovant, Inc.
14.25
-1.45%
RLAY Relay Therapeutics, Inc.
2.9300
+6.55%
EWTX Edgewise Therapeutics, Inc.
13.53
+1.73%
AKRO Akero Therapeutics, Inc.
38.50
+2.20%
NRSN NeuroSense Therapeutics Ltd.
1.0100
+3.25%
COGT Cogent Biosciences, Inc.
4.3400
+0.93%
TECX Tectonic Therapeutic, Inc.
19.49
+8.76%
SYRE Spyre Therapeutics, Inc.
13.96
+2.87%